Home
Lumenis

Lumenis Market Share Analysis for June 2026

Kendall Donaldson, MD, reviews the role of transcutaneous electrical stimulation (TCES) in dry eye disease (DED), including Dynamic Muscle Stimulation technology (DMSt) as a targeted approach to improving eyelid function.

Industry: N/A

Domainlumenis.com.au

Year Founded1966

Employees1001 - 5000

Annual Revenue$200M - $500M

Lumenis

Lumenis (including company regionals)

lumenis.com.au

See more website traffic and engagement information

Lumenis Revenue up to June 2026 is 200M - 500M

revenue generated by Lumenis top domains

Lumenis top domains revenue over 3 years

Revenue for Lumenis top domains

lumenis.com.au200M - 500M

See more with Sales Intelligence

Total visits to Lumenis's top domains

Understand Lumenis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

lumenis.com.au2.5K

See more with Sales Intelligence

Avg. visit duration in Lumenis's top domains

Analyze Lumenis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

lumenis.com.au00:00:25

See more with Sales Intelligence

Avg. pageviews on Lumenis's top domains

See how Lumenis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

lumenis.com.au1.54

See more with Sales Intelligence

Lumenis top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Lumenis

These are the website technologies, by industry, used by Lumenis top domains

Advertising (10)

Google Adsense

Widget (6)

Twemoji

Conversion & Analytics (3)

Google Analytics

Marketing (3)

Google Marketing Platform

More Technologies

10

See all

News & Signals from Lumenis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLumenis Be ANZ Pty Ltd launched FoLix on Jun 1st '24.Following its success in the United States since its debut in June 2024, Lumenis is marking a significant milestone in its international expansion with the launch of FoLix(TM) into the Australian market to help both men and women to look and feel their best by offering an effective and safe hair loss solution.

NewsLumenis Be ANZ Pty Ltd launches OptiPLUS in Australia.Lumenis BE ANZ has announced the launch of OptiPLUS in Australia and New Zealand, which the company says is the first-ever dual frequency radiofrequency (RF) device designed specifically for eyecare professionals.

NewsLumenis Be ANZ Pty Ltd launched Splendor X device to the UK market on Mar 1st '22.For instance, in March 2022, aesthetic device manufacturer Lumenis introduced the Splendor X device to the UK market.